Literature DB >> 2063206

Reconstruction and future trends of the AIDS epidemic in the United States.

R Brookmeyer1.   

Abstract

There has been considerable uncertainty in estimates of past and current human immunodeficiency virus (HIV) infection rates in the United States. Statistical estimates of historical infection rates can be obtained from acquired immunodeficiency syndrome (AIDS) incidence data and the incubation period. However, this approach is subject to a number of sources of uncertainty and two other approaches, epidemic models of HIV transmission and surveys of HIV prevalence, are used to corroborate and refine the statistical estimates. Analyses suggest the HIV infection rate in the United States grew rapidly in the early 1980s, peaked in the mid-1980s, and subsequently declined markedly. Due both to the decline in the underlying infection rate and to the development of effective therapies that may delay AIDS diagnosis, overall AIDS incidence may plateau during the next 5 years. However, the number of individuals with advanced HIV disease without a diagnosis of AIDS who could potentially benefit from therapy is expected to increase 40% by 1995 as infected individuals progress to more advanced stages of HIV disease. Thus, although the overall HIV infection rate has declined, the demands on the U.S. health care system for treatment and care of HIV-infected individuals remain enormous.

Entities:  

Mesh:

Year:  1991        PMID: 2063206     DOI: 10.1126/science.2063206

Source DB:  PubMed          Journal:  Science        ISSN: 0036-8075            Impact factor:   47.728


  32 in total

1.  Use of rapid behavioral assessments to determine the prevalence of HIV risk behaviors in high-risk populations.

Authors:  Kathleen M Gallagher; Paul D Denning; Denise R Allen; Allyn K Nakashima; Patrick S Sullivan
Journal:  Public Health Rep       Date:  2007       Impact factor: 2.792

2.  Caring for pets of immunocompromised persons.

Authors:  F J Angulo; C A Glaser; D D Juranek; M R Lappin; R L Regnery
Journal:  Can Vet J       Date:  1995-04       Impact factor: 1.008

3.  HIV and AIDS.

Authors:  A M Johnson
Journal:  BMJ       Date:  1991-09-07

4.  Preventing AIDS now.

Authors:  R J Biggar
Journal:  BMJ       Date:  1991-11-09

5.  Health-related quality of life of HIV-infected women: evidence for the reliability, validity and responsiveness of the Medical Outcomes Study Short-Form 20.

Authors:  M Y Smith; J Feldman; P Kelly; J A DeHovitz; K Chirgwin; H Minkoff
Journal:  Qual Life Res       Date:  1996-02       Impact factor: 4.147

6.  Modeling Disease Progression with Longitudinal Markers.

Authors:  Lurdes Y T Inoue; Ruth Etzioni; Christopher Morrell; Peter Müller
Journal:  J Am Stat Assoc       Date:  2008       Impact factor: 5.033

7.  Do people who develop AIDS within 12 months of HIV diagnosis delay HIV testing?

Authors:  Sandra K Schwarcz; Ling Hsu; Chi-Sheng Jennie Chin; T Anne Richards; Heidi Frank; Conrad Wenzel; James Dilley
Journal:  Public Health Rep       Date:  2011 Jul-Aug       Impact factor: 2.792

8.  The pharmacoeconomics of HIV disease.

Authors:  L A Lynn; K A Schulman; J M Eisenberg
Journal:  Pharmacoeconomics       Date:  1992-03       Impact factor: 4.981

Review 9.  Defining and measuring the costs of the HIV epidemic to business firms.

Authors:  P G Farnham
Journal:  Public Health Rep       Date:  1994 May-Jun       Impact factor: 2.792

10.  Estimation of HIV incidence in the United States.

Authors:  H Irene Hall; Ruiguang Song; Philip Rhodes; Joseph Prejean; Qian An; Lisa M Lee; John Karon; Ron Brookmeyer; Edward H Kaplan; Matthew T McKenna; Robert S Janssen
Journal:  JAMA       Date:  2008-08-06       Impact factor: 56.272

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.